1412281-24-3

Upstream product

• 1412280-84-2 (R)-6-((R)-3-hydroxy-4-methylpent-4-enyl)-3-methoxy-6-methylcyclohex-2-enone 
• 1412280-81-9 C₁₃H₂₀O₃ 
• 1412280-60-4 3-methoxy-6-(4-methyl-3-oxopent-4-enyl)cyclohex-2-enone 
• 1312767-99-9 6-[3'-hydroxy-4'-methylpent-4'-en-1'-yl]-3-methoxycyclohex-2-en-1-one 
• 1412280-94-4 (R)-4-methyl-4-(4-methylpent-4-enyl)-3-vinylcyclohex-2-enone 
• 1412280-90-0 (R)-3-methoxy-6-methyl-6-(4-methylpent-4-enyl)cyclohex-2-enone 
• 1412280-87-5 (R)-5-((R)-4-methoxy-1-methyl-2-oxocyclohex-3-enyl)-2-methylpent-1-en-3-yl acetate 

Relevant academic research and scientific papers

Stereoconvergent route to chiral cyclohexenone building blocks: Formal synthesis of (-)-dysidiolide

A stereoconvergent access to chiral carbocyclic building blocks is reported. 6-(3′-Hydroxy-4′-methylpent-4′-enyl)-3-methoxy cyclohex-2-enone (1) that consists of four stereoisomers, i.e., racemic ca. 1:1 diastereomers, is converted to enantiomerically pure carbocycles through a combination of regioselective catalytic asymmetric reduction and alkylative remote stereoinduction. The present stereoconvergent strategy has allowed the formal synthesis of bioactive (-)-dysidiolide.